Drug intelligence / Profile preview

HOMOPHENYLALANINYLMETHANE

Development stage
Unknown
01

Overview

HOMOPHENYLALANINYLMETHANE is a chemical compound with the molecular formula C11H15NO. It is identified in PubChem (CID 46937105) and has a DrugBank ID (DB07913), indicating its recognition as a substance with potential pharmaceutical relevance. It is classified under pharmaceuticals in ZINC15. However, specific details regarding its mechanism of action, therapeutic indications, or development status as a drug are not available in the provided information.

Other names
(3S)-3-amino-5-phenylpentan-2-oneRefChem:146757SCHEMBL10077590SCHEMBL-10077590SCHEMBL 10077590NS00072592NS-00072592NS 00072592

Beyond the preview

Go deeper on HOMOPHENYLALANINYLMETHANE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HOMOPHENYLALANINYLMETHANE.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call